260 related articles for article (PubMed ID: 26618098)
1. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol.
Arabi Y; Balkhy H; Hajeer AH; Bouchama A; Hayden FG; Al-Omari A; Al-Hameed FM; Taha Y; Shindo N; Whitehead J; Merson L; AlJohani S; Al-Khairy K; Carson G; Luke TC; Hensley L; Al-Dawood A; Al-Qahtani S; Modjarrad K; Sadat M; Rohde G; Leport C; Fowler R
Springerplus; 2015; 4():709. PubMed ID: 26618098
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia.
Arabi YM; Hajeer AH; Luke T; Raviprakash K; Balkhy H; Johani S; Al-Dawood A; Al-Qahtani S; Al-Omari A; Al-Hameed F; Hayden FG; Fowler R; Bouchama A; Shindo N; Al-Khairy K; Carson G; Taha Y; Sadat M; Alahmadi M
Emerg Infect Dis; 2016 Sep; 22(9):1554-61. PubMed ID: 27532807
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians.
Arabi YM; Al-Enezi F; Longuere KS; Balkhy HH; Al-Sultan M; Al-Omari A; Al-Hameed FM; Carson G; Shindo N; Fowler R
BMC Anesthesiol; 2016 Jul; 16(1):36. PubMed ID: 27405596
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) across the Gulf Corporation Council countries: Four years update.
Aly M; Elrobh M; Alzayer M; Aljuhani S; Balkhy H
PLoS One; 2017; 12(10):e0183850. PubMed ID: 29028812
[TBL] [Abstract][Full Text] [Related]
5. High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.
Alshukairi AN; Zheng J; Zhao J; Nehdi A; Baharoon SA; Layqah L; Bokhari A; Al Johani SM; Samman N; Boudjelal M; Ten Eyck P; Al-Mozaini MA; Zhao J; Perlman S; Alagaili AN
mBio; 2018 Oct; 9(5):. PubMed ID: 30377284
[TBL] [Abstract][Full Text] [Related]
6. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience.
Ko JH; Seok H; Cho SY; Ha YE; Baek JY; Kim SH; Kim YJ; Park JK; Chung CR; Kang ES; Cho D; Müller MA; Drosten C; Kang CI; Chung DR; Song JH; Peck KR
Antivir Ther; 2018; 23(7):617-622. PubMed ID: 29923831
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
Folegatti PM; Bittaye M; Flaxman A; Lopez FR; Bellamy D; Kupke A; Mair C; Makinson R; Sheridan J; Rohde C; Halwe S; Jeong Y; Park YS; Kim JO; Song M; Boyd A; Tran N; Silman D; Poulton I; Datoo M; Marshall J; Themistocleous Y; Lawrie A; Roberts R; Berrie E; Becker S; Lambe T; Hill A; Ewer K; Gilbert S
Lancet Infect Dis; 2020 Jul; 20(7):816-826. PubMed ID: 32325038
[TBL] [Abstract][Full Text] [Related]
8. Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai.
Lau SKP; Li KSM; Luk HKH; He Z; Teng JLL; Yuen KY; Wernery U; Woo PCY
mSphere; 2020 Jan; 5(1):. PubMed ID: 31969478
[TBL] [Abstract][Full Text] [Related]
9. Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability.
Kim YS; Aigerim A; Park U; Kim Y; Park H; Rhee JY; Choi JP; Park WB; Park SW; Kim Y; Lim DG; Choi JY; Jeon YK; Yang JS; Lee JY; Shin HS; Cho NH
Clin Infect Dis; 2021 Aug; 73(3):e550-e558. PubMed ID: 32898238
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) antibodies in dromedary camels in Israel.
Harcourt JL; Rudoler N; Tamin A; Leshem E; Rasis M; Giladi M; Haynes LM
Zoonoses Public Health; 2018 Sep; 65(6):749-754. PubMed ID: 29855166
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial.
Arabi YM; Alothman A; Balkhy HH; Al-Dawood A; AlJohani S; Al Harbi S; Kojan S; Al Jeraisy M; Deeb AM; Assiri AM; Al-Hameed F; AlSaedi A; Mandourah Y; Almekhlafi GA; Sherbeeni NM; Elzein FE; Memon J; Taha Y; Almotairi A; Maghrabi KA; Qushmaq I; Al Bshabshe A; Kharaba A; Shalhoub S; Jose J; Fowler RA; Hayden FG; Hussein MA;
Trials; 2018 Jan; 19(1):81. PubMed ID: 29382391
[TBL] [Abstract][Full Text] [Related]
12. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.
Choe PG; Perera RAPM; Park WB; Song KH; Bang JH; Kim ES; Kim HB; Ko LWR; Park SW; Kim NJ; Lau EHY; Poon LLM; Peiris M; Oh MD
Emerg Infect Dis; 2017 Jul; 23(7):1079-1084. PubMed ID: 28585916
[TBL] [Abstract][Full Text] [Related]
13. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection.
Arabi YM; Arifi AA; Balkhy HH; Najm H; Aldawood AS; Ghabashi A; Hawa H; Alothman A; Khaldi A; Al Raiy B
Ann Intern Med; 2014 Mar; 160(6):389-97. PubMed ID: 24474051
[TBL] [Abstract][Full Text] [Related]
14. Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar.
Al Kahlout RA; Nasrallah GK; Farag EA; Wang L; Lattwein E; Müller MA; El Zowalaty ME; Al Romaihi HE; Graham BS; Al Thani AA; Yassine HM
J Immunol Res; 2019; 2019():1386740. PubMed ID: 30906787
[TBL] [Abstract][Full Text] [Related]
15. Early identification of pneumonia patients at increased risk of Middle East respiratory syndrome coronavirus infection in Saudi Arabia.
Ahmed AE; Al-Jahdali H; Alshukairi AN; Alaqeel M; Siddiq SS; Alsaab H; Sakr EA; Alyahya HA; Alandonisi MM; Subedar AT; Aloudah NM; Baharoon S; Alsalamah MA; Al Johani S; Alghamdi MG
Int J Infect Dis; 2018 May; 70():51-56. PubMed ID: 29550445
[TBL] [Abstract][Full Text] [Related]
16. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study.
Müller MA; Meyer B; Corman VM; Al-Masri M; Turkestani A; Ritz D; Sieberg A; Aldabbagh S; Bosch BJ; Lattwein E; Alhakeem RF; Assiri AM; Albarrak AM; Al-Shangiti AM; Al-Tawfiq JA; Wikramaratna P; Alrabeeah AA; Drosten C; Memish ZA
Lancet Infect Dis; 2015 May; 15(5):559-64. PubMed ID: 25863564
[TBL] [Abstract][Full Text] [Related]
17. Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study.
Memish ZA; Al-Tawfiq JA; Makhdoom HQ; Al-Rabeeah AA; Assiri A; Alhakeem RF; AlRabiah FA; Al Hajjar S; Albarrak A; Flemban H; Balkhy H; Barry M; Alhassan S; Alsubaie S; Zumla A
Clin Microbiol Infect; 2014 May; 20(5):469-74. PubMed ID: 24460984
[TBL] [Abstract][Full Text] [Related]
18. The Middle East Respiratory Syndrome Coronavirus - A Continuing Risk to Global Health Security.
Azhar EI; Lanini S; Ippolito G; Zumla A
Adv Exp Med Biol; 2017; 972():49-60. PubMed ID: 27966107
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
[TBL] [Abstract][Full Text] [Related]
20. Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests.
Ko JH; Müller MA; Seok H; Park GE; Lee JY; Cho SY; Ha YE; Baek JY; Kim SH; Kang JM; Kim YJ; Jo IJ; Chung CR; Hahn MJ; Drosten C; Kang CI; Chung DR; Song JH; Kang ES; Peck KR
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2179-2186. PubMed ID: 28695355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
